Warning: For any media inquiries, please contact presse@pasteur.fr

Our press documents

You are a journalist and you would like to receive our press releases by e-mail? Please, ask to presse@pasteur.fr

Filter press documents

Une étude préclinique montre que l’hydroxychloroquine n’a pas d’effet antiviral contre le SARS-CoV-2 in vivo
Press release
29.05.2020
A study on the effects of hydroxychloroquine n macaques infected with the SARS-CoV-2 virus, used alone or in...
Press release
26.05.2020
Teams from Strasbourg University Hospital and the Institut Pasteur carried out a study among hospital staff on the two...
Candidat vaccin MV-SARS-CoV-2 : un nouveau partenariat entre l’Institut Pasteur, la CEPI, Thémis et MSD
Press release
26.05.2020
Institut Pasteur announces recent advances in the development of one of its candidate vaccines, MV-SARS-CoV-2, using...
VIH : une fenêtre de vulnérabilité pour le renouvellement du réservoir viral après allogreffe de cellules souches
Press release
07.05.2020
Current HIV treatments efficiently block viral multiplication but cannot cure infection as they do not target HIV...
Press release
30.04.2020
An international effort including researchers from University of California San Francisco (UCSF), Gladstone Institutes...
Press Info
28.04.2020
Following the emergence of COVID-19 disease in Wuhan in December 2019, syndromic surveillance was implemented in France...
Press release
24.04.2020
Approximately four months after the initial description of cases of atypical pneumonia in Wuhan, China, in December...
Formule
Press release
21.04.2020
The SARS-CoV-2 global pandemic has resulted in extreme measures, with several countries imposing a lockdown on their...
Shigella
Press release
16.04.2020
The Bill & Melinda Gates Medical Research Institute (Gates MRI) and the Institut Pasteur have entered into an...

Pages

 

Subscribe to our newsletter

Back to top